Divi's Laboratories Limited

NSEI:DIVISLAB Stock Report

Market Cap: ₹1.5t

Divi's Laboratories Future Growth

Future criteria checks 4/6

Divi's Laboratories is forecast to grow earnings and revenue by 23.7% and 16.3% per annum respectively. EPS is expected to grow by 23.7% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

23.7%

Earnings growth rate

23.7%

EPS growth rate

Life Sciences earnings growth22.8%
Revenue growth rate16.3%
Future return on equity17.3%
Analyst coverage

Good

Last updated12 Nov 2024

Recent future growth updates

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Aug 06
Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Jul 19
The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Recent updates

Revenues Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)

Sep 06
Revenues Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)

Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Aug 06
Earnings Miss: Divi's Laboratories Limited Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Jul 19
The Divi's Laboratories Limited (NSE:DIVISLAB) Yearly Results Are Out And Analysts Have Published New Forecasts

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Apr 19
Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Dec 27
Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Earnings and Revenue Growth Forecasts

NSEI:DIVISLAB - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027128,33932,72417,08626,78324
3/31/2026108,29826,40412,16423,21427
3/31/202592,41520,4984,85420,72326
9/30/202486,14018,3604,75016,480N/A
6/30/202481,85016,740N/AN/AN/A
3/31/202478,45016,0002,58012,610N/A
12/31/202374,92613,834N/AN/AN/A
9/30/202373,45613,3147,92715,127N/A
6/30/202372,90614,774N/AN/AN/A
3/31/202377,67018,24019,86024,590N/A
12/31/202283,35323,971N/AN/AN/A
9/30/202291,20829,92522,15328,404N/A
6/30/202292,53831,054N/AN/AN/A
3/31/202289,59929,60511,98619,118N/A
12/31/202182,29725,678N/AN/AN/A
9/30/202174,37921,3624,76013,465N/A
6/30/202171,99620,493N/AN/AN/A
3/31/202169,69519,84310,36719,469N/A
12/31/202065,71018,705N/AN/AN/A
9/30/202062,65817,59010,71420,167N/A
6/30/202059,62015,962N/AN/AN/A
3/31/202053,94513,76532712,159N/A
12/31/201952,71912,803N/AN/AN/A
9/30/201952,35613,106-3,4307,962N/A
6/30/201951,13913,575N/AN/AN/A
3/31/201949,46313,5272,2129,543N/A
3/31/201838,9158,770N/A7,759N/A
3/31/201740,64310,604N/A11,504N/A
3/31/201637,76411,258N/A10,379N/A
3/31/201531,0498,515N/A8,263N/A
3/31/201425,2677,733N/A5,567N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DIVISLAB's forecast earnings growth (23.7% per year) is above the savings rate (6.7%).

Earnings vs Market: DIVISLAB's earnings (23.7% per year) are forecast to grow faster than the Indian market (18.1% per year).

High Growth Earnings: DIVISLAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DIVISLAB's revenue (16.3% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: DIVISLAB's revenue (16.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DIVISLAB's Return on Equity is forecast to be low in 3 years time (17.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:26
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Divi's Laboratories Limited is covered by 54 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAntique Stockbroking Ltd.